B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptide
BCAP31
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN973765
Aperçu rapide pour B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptide (ABIN973765)
Antigène
BCAP31
(B-Cell Receptor-Associated Protein 31 (BCAP31))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
Middle Region
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-BCAP31 antibody (Catalog #: ARP46645_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
BCAP31
(B-Cell Receptor-Associated Protein 31 (BCAP31))
Sujet
BCAP31 is a member of the B-cell receptor associated protein 31 superfamily. It is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in the caspase 8-mediated apoptosis. Microdeletions in this gene are associated with the contiguous ABCD1/DXS1375E deletion syndrome.
Alias Symbols: 6C6-AG, BAP31, CDM, DXS1357E
Protein Interaction Partner: PTPLB,ACTG1,APP,BCAP29,BCAP31,BCL2,BCL2L1,CANX,CASP1,CASP3,CASP8,HLA-A,MSN,MYH10,PLP2,PTPLB,VAMP1,VAMP3,ACTG1,BCAP29,BCAP31,BCL2,BCL2L1,CASP1,CASP8,MYH10,VAMP2,VAMP3